Prevnar 20 2.2 mcg (Pneumococcal Polysaccharide Serotype 14) Suspension

PREVNAR 20 is a pneumococcal vaccine designed to help prevent pneumococcal disease. This suspension is administered intramuscularly and is suitable for individuals at risk of pneumococcal infections.

PREVNAR 20 is used to help protect against pneumococcal disease, which can cause serious infections like pneumonia, meningitis, and bacteremia. This vaccine targets specific serotypes of the pneumococcus bacteria, including serotype 14, to reduce the risk of infection in at-risk populations.

Common effects of PREVNAR 20 may include mild redness, swelling, or pain at the injection site. Some individuals might experience temporary fever, fatigue, or muscle aches following vaccination. These effects are generally mild and short-lived.

PREVNAR 20 should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform your healthcare provider about any current illnesses or allergies before receiving the vaccine.

PREVNAR 20 may interact with other vaccines or medications. It is generally recommended to space out the administration of other vaccines. Always consult a healthcare provider for personalized advice regarding potential interactions.